Cite
HARVARD Citation
Pastor, B. et al. (2021). Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment. Molecular oncology. 15 (9), pp. 2401-2411. [Online].